SUVEN LIFE SCIENCES LTD Financial Ratios
SUVEN · Healthcare · Current price ₹380.15
P/E ratio
-29.5x
P/B ratio
13.3x
ROE
-78.8%
ROCE
-77.0%
Debt / Equity
0.01
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -29.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 13.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -78.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -77.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.01 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SUVEN LIFE SCIENCES LTD's latest numbers.
SUVEN LIFE SCIENCES LTD profitability
SUVEN LIFE SCIENCES LTD generates a return on equity of -78.8% and a return on capital employed of -77.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.01 and a P/E of -29.5x, SUVEN LIFE SCIENCES LTD is conservatively financed. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on SUVEN LIFE SCIENCES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.